Hiroyuki Terakado

Ebara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Concerns and Consultation Needs for Hospital and Community Pharmacists at Metastatic or Recurrent Cancer Diagnosis: A Web-Based Survey in Japan.

Concerns and Consultation Needs for Hospital and Community Pharmacists at Metastatic or Recurrent Cancer Diagnosis: A Web-Based Survey in Japan.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: August 03, 2026

Relationship of pre-diagnosis pharmacist continuity with patient-reported satisfaction at the first post-diagnosis community pharmacy visit among adolescents and young adults with cancer: a nationwide cross-sectional online survey.

Relationship of pre-diagnosis pharmacist continuity with patient-reported satisfaction at the first post-diagnosis community pharmacy visit among adolescents and young adults with cancer: a nationwide cross-sectional online survey.

Journal: Journal of pharmaceutical health care and sciences

Published: March 25, 2026

Experience-based ambivalence toward medical opioid use among Japanese adults: a nationwide cross-sectional survey using the barriers questionnaire II.

Experience-based ambivalence toward medical opioid use among Japanese adults: a nationwide cross-sectional survey using the barriers questionnaire II.

Journal: Journal of pharmaceutical health care and sciences

Published: October 26, 2025

Association of family pharmacist continuity with patient-reported satisfaction in patients with metastatic cancer: a nationwide cross-sectional study.

Association of family pharmacist continuity with patient-reported satisfaction in patients with metastatic cancer: a nationwide cross-sectional study.

Journal: Journal of pharmaceutical health care and sciences

Published: October 19, 2025

Cross-sectional survey on cancer patients' concerns and consultation needs with pharmacists at the time of initial diagnosis.

Cross-sectional survey on cancer patients' concerns and consultation needs with pharmacists at the time of initial diagnosis.

Journal: Journal of pharmaceutical health care and sciences

Published: May 25, 2025

A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemic.

A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemic.

Journal: Global health & medicine

Published: December 20, 2023

Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.

Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.

Journal: Scientific reports

Published: April 17, 2023

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.

Journal: Frontiers in oncology

Published: March 17, 2022

Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system.

Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system.

Journal: Global health & medicine

Published: March 01, 2022

Study for Management Status of Hepatitis B Virus Reactivation Caused by Cancer Chemotherapy in High-Risk Cases

Study for Management Status of Hepatitis B Virus Reactivation Caused by Cancer Chemotherapy in High-Risk Cases

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: November 19, 2021

Are Platinum Drugs Ineffective for Triple-Negative Breast Cancer With Residual Invasive Disease After Neoadjuvant Chemotherapy?

Are Platinum Drugs Ineffective for Triple-Negative Breast Cancer With Residual Invasive Disease After Neoadjuvant Chemotherapy?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 23, 2021

Adjuvant Treatment for Small-Size, Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Escalation or De-Escalation?

Adjuvant Treatment for Small-Size, Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Escalation or De-Escalation?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 10, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026